In this issue, were diving deeper into the potential benefits of GLP-1 agonist medicationswidely known for treating diabetes and weight managementon neurological, cardiovascular, and immune system health
(A 2022 clinical trial published in the New England Journal of Medicine found that roughly 80% of people taking Zepbound did.) Research and obesity medicine specialists have identified a few common patterns for when symptoms tend to flare up: Early on, especially during the first few weeks Within 48 hours of an injection After a dose increase Individual bouts of nausea, diarrhea and vomiting often pass within a few days, though constipation can stick around much longer
Acknowledgements The National Natural Science Foundation of China (NSFC) (grant number 82171575) and the Hubei Provincial Clinical Medical Research Center for Nephropathy (grant number OIR202402Z) were gratefully acknowledged
Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people
Guided by board-certified physicians and supported by a multidisciplinary team, the program includes oral Finasteride treatment, virtual check-ins, and comprehensive support from hair care specialists, nutritionists, and fitness instructors
Any trend toward higher fasting glucose or declining insulin sensitivity should trigger protocol reassessment